{"gao_id": "GAO-21-319", "published": "2021-02-11T12:00:00Z", "released": "2021-02-11T07:00:00Z", "summary": "Operation Warp Speed was a federal effort that supported multiple COVID-19 vaccine candidates to speed up development. We analyzed the program's vaccine candidates and found that their development followed traditional practices, with some adaptations. For example, some clinical trial phases overlapped with each other and with animal studies to accelerate development. Two vaccines were authorized for emergency use\u2014our tracker shows all the candidates. We also...", "title": "Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges", "topics": ["Laboratory equipment", "Drug testing", "Public health emergencies", "Technical challenges", "New drugs", "Research and development", "Vaccination", "Clinical trials", "Drug approvals", "Capacity management", "pandemics", "Health risks", "Health Care", "Manufacturing", "Immunizations", "Disease control", "Safety", "Public health", "Deaths"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-21-319", "versions": [{"title": "Highlights Page (2 pages)", "url": "https://www.gao.gov/assets/gao-21-319-highlights.pdf"}, {"title": "Full Report (47 pages)", "url": "https://www.gao.gov/assets/gao-21-319.pdf"}, {"title": "Accessible PDF (54 pages)", "url": "https://www.gao.gov/assets/720/712410.pdf"}]}